Skip to content
Logo
  • Solutions
    Solutions
    • R&D Teams
    • Regulatory Teams
    • Commercial Teams
    • HEOR Teams
    • Cancer Centers and Oncologists
  • Products
    Products
    • Focus
    • Vantage
    • Vista
    • Clinicogenomics
    • Real-World Analytics
  • Services
    Services
    • Real-World Insights & Support
  • About Us
    About Us
    • Our Mission
    • Careers
  • Resources
    Resources
    • Research
    • Blog
    • News
    • Podcasts
    • Case Studies

    How real-world ovarian cancer data will improve outcomes for women

    Read More

    Minimizing “missingness” in cancer mortality statistics with real-world data

    Read More
Contact Us

Day: June 22, 2022

COTA Research Showcased High Concordance Rate Between Real-World Physician Response Assessment & the 2017 European LeukemiaNet (ELN) Criteria for Acute Myeloid Leukemia at EHA2022

COTA researchers and collaborators’s recent abstract in the European Hematology Association’s library, found that overall agreement between response categories was 65.1% among AML data.

Logo
footer-background
Solutions
  • R&D Teams
  • Regulatory Teams
  • Commercial Teams
  • HEOR Teams
  • Oncology Providers
Products & Services
  • Focus
  • Vantage
  • Vista
  • Clinicogenomics
  • Real-World Analytics
  • Real-World Insights & Support
About Us
  • Our Mission
  • Careers
  • Become a Data Partner
Follow Us
  • LinkedIn
  • Real World Talk with COTA
  • Real World Talk with COTA
© 2025 COTA. All rights reserved.
  • Privacy Policy
  • Terms of Service
  • CCPA Privacy Notice